Concentration of cytokines in patients with osteoarthritis of the knee and fibromyalgia

Clinical Interventions in Aging

Volumn 9, Issue , 2014, Pages 939-944

  Imamura, Marta ^a   Targino, Rosa Alves ^a   Hsing, Wu Tu ^a   Imamura, Satiko ^a   Azevedo, Raymundo Soares ^a   Villas Boas, Lucy Santos ^a   Tozetto Mendoza, Tania Regina ^a   Alfieri, Fábio Marcon ^a,b   Filippo, Thais Raquel ^a   Battistella, Linamara Rizzo ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b São Paulo Adventist University   (Brazil)

Author keywords

Aging; Cytokines; Fibromyalgia; Osteoarthritis

Indexed keywords

CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 12P70; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR; INTERLEUKIN 12; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; AGING; ARTICLE; BLOOD SAMPLING; BODY MASS; CENTRIFUGATION; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE SEVERITY; FEMALE; FIBROMYALGIA; HUMAN; KNEE OSTEOARTHRITIS; MAJOR CLINICAL STUDY; PROTEIN BLOOD LEVEL; VISUAL ANALOG SCALE; BLOOD; COMPARATIVE STUDY; MIDDLE AGED; PAIN MEASUREMENT;

AGED; CYTOKINES; FEMALE; FIBROMYALGIA; HUMANS; INTERLEUKIN-10; INTERLEUKIN-12; INTERLEUKIN-1BETA; INTERLEUKIN-6; INTERLEUKIN-8; MIDDLE AGED; OSTEOARTHRITIS, KNEE; PAIN MEASUREMENT; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84902344797     PISSN: 11769092     EISSN: 11781998     Source Type: Journal    
DOI: 10.2147/CIA.S60330     Document Type: Article

References (42)

1. Alkan BM, Fidan F, Tosun A, Ardiçoǧlu O. Quality of life and self-reported disability in patients with knee osteoarthritis. Mod Rheumatol. 2014;24(1):166-171.
2. Kotlarz H, Gunnarsson CL, Fang H, Rizzo JA. Insurer and out-of-pocket costs of osteoarthritis in the US: evidence from national survey data. Arthritis Rheum. 2009;60(12):3546-3553.
3. Ang DC, Moore MN, Hilligoss J, Tabbey R. MCP-1 and IL-8 as pain biomarkers in fibromyalgia: a pilot study. Pain Med. 2011;12(8):1154-1161.
4. Centers for Disease Control and Prevention. Fibromyalgia. 2012. Available from: http://www.cdc.gov/arthritis/basics/fibromyalgia.htm. Accessed December 6, 2013.
5. Forseth KO, Gran JT. The prevalence of fibromyalgia among women aged 20-49 years in Arendal, Norway. Scand J Rheumatol. 1992; 21(2):74-78.
6. Pongratz DE, Sievers M. Fibromyalgia - symptom or diagnosis: a definition of the position. Scand J Rheumatol Suppl. 2000;113:3-7.
7. Russel IJ. Fibromalgia syndrome. In: Loeser JD, Butler SH, Chapman CR, Turkey DC, editors. Bonica's Management of Pain. 3rd ed. Philadeplphia: Lippincott Williams & Wilkins; 2001:543-556.
8. Menzies V, Lyon DE. Integrated review of the association of cytokines with fibromyalgia and fibromyalgia core symptoms. Biol Res Nurs. 2010;11(4):387-394.
9. Hassett AL, Epel E, Clauw DJ, et al. Pain is associated with short leukocyte telomere length in women with fibromyalgia. J Pain. 2012; 13(10):959-969.
10. Curfs J, Meis J, Hoogkamp-Korstanje J. A primer on cytokines: sources, receptors, effects, and inducers. Clin Microbiol Rev. 1997;10(4): 742-780.
11. Uçeyler N, Häuser W, Sommer C. Systematic review with meta-analysis: cytokines in fibromyalgia syndrome. BMC Musculoskelet Disord. 2011;12:245.
12. Wallace DJ, Linker-Israeli M, Hallegua D, Silverman S, Silver D, Weisman MH. Cytokines play an aetiopathogenetic role in fibromyalgia: a hypothesis and pilot study. Rheumatology (Oxford). 2001;40(7): 743-749.
13. Gür A, Karakoç M, Nas K, et al. Cytokines and depression in cases with fibromyalgia. J Rheumatol. 2002;29(2):358-361.
14. Bazzichi L, Rossi A, Massimetti G, et al. Cytokine patterns in fibromyalgia and their correlation with clinical manifestations. Clin Exp Rheumatol. 2007;25(2):225-230.
15. Wang H, Buchner M, Moser MT, Daniel V, Schiltenwolf M. The role of IL-8 in patients with fibromyalgia: a prospective longitudinal study of 6 months. Clin J Pain. 2009;25(1):1-4.
16. Togo F, Natelson BH, Adler GK, et al. Plasma cytokine fluctuations over time in healthy controls and patients with fibromyalgia. Exp Biol Med. 2009;234(2):232-240.
17. Livshits G, Zhai G, Hart DJ, et al. Interleukin-6 is a significant predictor of radiographic knee osteoarthritis: the Chingford Study. Arthritis Rheum. 2009;60(7):2037-2045.
18. Levinger I, Levinger P, Trenerry MK, et al. Increased inflammatory cytokine expression in the vastus lateralis of patients with knee osteoarthritis. Arthritis Rheum. 2011;63(5):1343-1348.
19. Chapman RS, Syrjala KL. Measurement of pain. In: Bonica JJ, editor. The Management of Pain. 2nd ed. London: Lea & Febiger; 1990:580-594.
20. Wolfe F, Smythe HA, Yunus MB, et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum. 1990;33(2): 160-172.
21. Altman R, Asch E, Bloch D, et al. Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association. Arthritis Rheum. 1986;29(8): 1039-1049.
22. Ravaud P, Auleley GR, Chastang C, et al. Knee joint space width measurement: an experimental study of the influence of radiographic procedure and joint positioning. Br J Rheumatol. 1996;35(8):761-766.
23. Kirkwood BR, Sterne JAC. Essential Medical Statistics. 2nd ed. Massachusetts: Blackwell Science; 2006.
24. Miller GD, Nicklas BJ, Loeser RF. Inflammatory biomarkers and physical function in older, obese adults with knee pain and self-reported osteoarthritis after intensive weight-loss therapy. J Am Geriatr Soc. 2008;56(4):644-651.
25. Pelletier JP, Martel-Pelletier J, Abramson SB. Osteoarthritis, an inflammatory disease: potential implication for the selection of new therapeutic targets. Arthritis Rheum. 2001;44(6):1237-1247.
26. Saxne T, Lindell M, Månsson B, Petersson IF, Heinegård D. Inflammation is a feature of the disease process in early knee joint osteoarthritis. Rheumatology. 2003;42(7):903-904.
27. Ferrucci L, Penninx BW, Volpato S, et al. Change in muscle strength explains accelerated decline of physical function in older women with high interleukin-6 serum levels. J Am Geriatr Soc. 2002;50(12): 1947-1954.
28. Penninx BW, Abbas H, Ambrosius W, et al. Inflammatory markers and physical function among older adults with knee osteoarthritis. J Rheumatol. 2004;31(10):2027-2031.
29. Ferraro KF, Booth TL. Age, body mass index, and functional illness. J Gerontol B Psychol Sci Soc Sci. 1999;54(6):S339-S348.
30. Wallace DJ. Is there a role for cytokine based therapies in fibromyalgia. Curr Pharm Des. 2006;12(1):17-22.
31. Mobily PR, Herr KA, Clark MK, Wallace RB. An epidemiologic analysis of pain in the elderly: the Iowa 65+ health study. J Aging Health. 1994;6(2):139-154.
32. Diatchenko L, Nackley AG, Slade GD, Fillingim RB, Maixner W. Idiopathic pain disorders - pathways of vulnerability. Pain. 2006; 123(3):226-230.
33. Staud R. Treatment of fibromyalgia and its symptoms. Expert Opin Pharmacother. 2007;8(11):1629-1642.
34. Ortega E, García JJ, Bote ME, et al. Exercise in fibromyalgia and related inflammatory disorders: known effects and unknown chances. Exerc Immunol Rev. 2009;15:42-65.
35. Maddali Bongi S, Del Rosso A. [How to prescribe physical exercise in rheumatology]. Reumatismo. 2010;62(1):4-11. Italian.
36. Helmark IC, Mikkelsen UR, Børglum J, et al. Exercise increases interleukin-10 levels both intraarticularly and peri-synovially in patients with knee osteoarthritis: a randomized controlled trial. Arthritis Res Ther. 2010;12(4):R126.
37. Ferrero-Miliani L, Nielsen OH, Andersen OS, Girardin SE. Chronic inflammation: importance of NOD2 and NALP3 in interleukin-1β generation. Clin Exp Immunol. 2006;147(2):227-235.
38. Peake J, Della Gatta P, Cameron-Smith D. Aging and its effects on inflammation in skeletal muscle at rest and following exercise-induced muscle injury. Am J Physiol Regul Integr Comp Physiol. 2010;298(6):R1485-R1495.
39. Staud R. Peripheral pain mechanisms in chronic widespread pain. Best Pract Res Clin Rheumatol. 2011;25(2):155-164.
40. Iannone F, Lapadula G. Obesity and inflammation - targets for OA therapy. Curr Drug Targets. 2010;11(5):586-598.
41. World Health Organization. Physical Status: The Use and Interpretation of Anthropometry. Geneva: WHO; 1995.
42. Salemi S, Rethage J, Wollina U, et al. Detection of interleukin 1beta (IL-1beta), IL-6, and tumor necrosis factor-alpha in skin of patients with fibromyalgia. J Rheumatol. 2003;30(1):146-150.